UB Paderborn / Katalog / Suche / in CDI

Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA

Genome research, 2014-06, Vol.24 (6), p.1020

2014

Link zum Volltext

Verfügbarkeit prüfen

Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection

Science (American Association for the Advancement of Science), 2015-10, Vol.350 (6260), p.563-567

2015

Link zum Volltext

Verfügbarkeit prüfen

In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery

Nature communications, 2016-10, Vol.7 (1), p.13304-14, Article 13304

2016

Link zum Volltext

Verfügbarkeit prüfen

Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia

Scientific reports, 2018-10, Vol.8 (1), p.15041-10, Article 15041

2018

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice

PLoS pathogens, 2019-12, Vol.15 (12), p.e1008161-e1008161

2019

Link zum Volltext

Verfügbarkeit prüfen

Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice

Molecular therapy. Nucleic acids, 2016, Vol.5 (1), p.e280-e280, Article e280

2016

Link zum Volltext

Verfügbarkeit prüfen

Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication

International journal of nanomedicine, 2015-01, Vol.10 (default), p.903-921

2015

Link zum Volltext

Verfügbarkeit prüfen

Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial)

Infectious diseases and therapy, 2023-12, Vol.12 (12), p.2691-2707

2023

Link zum Volltext

Verfügbarkeit prüfen

Long‐acting and extended‐release implant and nanoformulations with a synergistic antiretroviral two‐drug combination controls HIV‐1 infection in a humanized mouse model

Bioengineering & translational medicine, 2022-01, Vol.7 (1), p.e10237-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Serum Lipids Can Convert Bovine Myogenic Satellite Cells to Adipocytes

ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES, 2010, 23(11), , pp.1519-1526

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc

AIDS (London), 2022-01, Vol.36 (1), p.11-18

2022

Link zum Volltext

Verfügbarkeit prüfen

Blocking Fas-signaling in adipocytes and hepatocytes prevents obesity-associated inflammation, insulin resistance, and hepatosteatosis

Journal of industrial and engineering chemistry (Seoul, Korea), 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile Virus

Cell host & microbe, 2018-04, Vol.23 (4), p.549-556.e3

2018

Link zum Volltext

Verfügbarkeit prüfen

Analysis of SARS-CoV-2 Emergent Variants Following AZD7442

Infectious diseases and therapy, 2023-12, Vol.12 (12), p.2691

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine

Antimicrobial agents and chemotherapy, 2022-03, Vol.66 (3), p.e0170221-e0170221

2022

Link zum Volltext

Verfügbarkeit prüfen

Low lysine treatment increases adipogenic potential of bovine intramuscular preadipocytes

ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES, 2009, 22(5), , pp.721-726

2009

Link zum Volltext

Verfügbarkeit prüfen

From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection

Proceedings of the National Academy of Sciences - PNAS, 2018-01, Vol.115 (4), p.E802-E811

2018

Link zum Volltext

Verfügbarkeit prüfen

REPLY TO PANDEY ET AL: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mousemodel of HIV infection

Proceedings of the National Academy of Sciences - PNAS, 2018-08, Vol.115 (35), p.E8114-E8115

2018

Link zum Volltext

Verfügbarkeit prüfen

Adenovirus-Vectored Broadly Neutralizing Antibodies Directed Against gp120 Prevent Human Immunodeficiency Virus Type 1 Acquisition in Humanized Mice

Human gene therapy, 2015-09, Vol.26 (9), p.622

2015

Link zum Volltext

Verfügbarkeit prüfen

Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA

Biomaterials, 2012-02, Vol.33 (5), p.1640-1650

2012

Link zum Volltext

Verfügbarkeit prüfen

Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA

Journal of drug targeting, 2017-04, Vol.25 (4), p.320-329

2017

Link zum Volltext

Verfügbarkeit prüfen

Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection

Molecular pharmacology, 2017-04, Vol.91 (4), p.383-391

2017

Link zum Volltext

Verfügbarkeit prüfen

Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV

Antiviral research, 2019-07, Vol.167 (7, 2019), p.110-116

2019

Link zum Volltext

Verfügbarkeit prüfen

Cationic cell-penetrating peptides as vehicles for siRNA delivery

Therapeutic delivery, 2015-04, Vol.6 (4), p.491-507

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA

Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection

In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery

Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia

Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice

Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice

Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication

Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial)

Long‐acting and extended‐release implant and nanoformulations with a synergistic antiretroviral two‐drug combination controls HIV‐1 infection in a humanized mouse model

Serum Lipids Can Convert Bovine Myogenic Satellite Cells to Adipocytes

Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc

Blocking Fas-signaling in adipocytes and hepatocytes prevents obesity-associated inflammation, insulin resistance, and hepatosteatosis

Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile Virus

Analysis of SARS-CoV-2 Emergent Variants Following AZD7442

Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine

Low lysine treatment increases adipogenic potential of bovine intramuscular preadipocytes

From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection

Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir

REPLY TO PANDEY ET AL: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mousemodel of HIV infection

Adenovirus-Vectored Broadly Neutralizing Antibodies Directed Against gp120 Prevent Human Immunodeficiency Virus Type 1 Acquisition in Humanized Mice

Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA

Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA

Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection

Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV

Cationic cell-penetrating peptides as vehicles for siRNA delivery

Suchergebnisse filtern